阿洛普雷格纳诺龙向核蛋白作为一种新型流感病毒抑制剂
Meiyue Dong1, Yanyan Wang2, Ping Li2
1Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Virologica Sinica
|September 23, 2023
概括
一种抗抑郁药Allopregnanolone (ALLO) 显示出作为一种新型流感A病毒 (IAV) 抑制剂的前景. 它通过向核蛋白 (NP) 运输来阻止病毒复制,为抗药IAV提供了一个新的策略.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 神经科学是一个神经科学.
背景情况:
- 流感A型病毒 (IAV) 构成了全球重大健康挑战.
- 越来越多的抗病毒耐药性需要新的治疗剂.
- 批准的抗抑郁药类药物阿洛普雷格纳诺 (ALLO) 有可能被重新使用.
研究的目的:
- 调查所有孕原 (ALLO) 作为对IAV的潜在抗病毒药物.
- 为了阐明ALLO对IAV的作用机制.
- 探索ALLO与现有抗病毒化合物的协同作用.
主要方法:
- 在体外研究使用IAV感染的细胞培养物.
- 机械测试以确定ALLO对病毒核蛋白 (NP) 转移的影响.
- 与血凝素抑制剂 (化合物16) 的联合研究.
主要成果:
- ALLO 显示显著抑制了 IAV 复制.
- 发现ALLO干扰了病毒NP的核导入.
- 当ALLO与化合物16结合使用时,观察到协同抗病毒活性.
结论:
- 标识Allopregnanolone (ALLO) 是一种新的IAV抑制剂.
- 该机制涉及病毒NP核转移的中断.
- 艾洛代表了作为抗流感治疗药物进一步发展的有希望的候选者.
更多相关视频
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
17.9K
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.3K
相关概念视频
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Subviral Agents
33
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
33
